All Stories

  1. Impact of SARS-CoV-2 Pandemic on Pediatric Inpatients with Invasive Group A Streptococcal Infections (iGAS): Results of a National Survey
  2. Untargeted Metabolite Profile Associations With Body Mass Index, Waist–Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study
  3. Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers
  4. Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study
  5. Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop
  6. Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009–2022
  7. Diet Diversity and Adherence to a Mediterranean Diet Pattern in Pregnancy Is Protective Against the Development of Early-Childhood Atopic Dermatitis
  8. Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study
  9. Types of Myocardial Infarction in People With HIV in Switzerland
  10. Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017–2024 Time-series Analysis of National Data
  11. Outcomes After Prenatal Exposure to Raltegravir-Containing Antiretroviral Therapy: A Multicohort European Study
  12. Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022
  13. Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity
  14. Fluorescent Probe for the pH-Independent Rapid and Sensitive Direct Detection of Urease-Producing Bacteria
  15. Burden of post–acute COVID-19 sequelae in healthcare workers and its course over a 30-month period–results from a prospective multicentre cohort
  16. Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study
  17. Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study
  18. HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
  19. Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)
  20. Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
  21. Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis
  22. SARS‐CoV‐2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study
  23. Clinical Characteristics and Management of Children and Adolescents Hospitalized With Pyomyositis
  24. Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study
  25. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study
  26. Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter
  27. Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination – a retrospective cohort study
  28. S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
  29. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort
  30. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients
  31. Organ Dysfunction in Children With Blood Culture-Proven Sepsis: Comparative Performance of Four Scores in a National Cohort Study
  32. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study
  33. Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies
  34. SARS-CoV-2 risk in household contacts of healthcare workers: a prospective cohort study
  35. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study
  36. Development of hybrid immunity during a period of high incidence of Omicron infections
  37. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study
  38. Sensitivity of ICD coding for sepsis in children—a population-based study
  39. Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals (SURPRISE study)
  40. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
  41. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study
  42. Reply to Zeng and Zhou
  43. Successful implementation of new Swiss recommendations on breastfeeding of infants born to women living with HIV
  44. Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021): a longitudinal study in Switzerland
  45. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
  46. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
  47. The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model
  48. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry
  49. Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland – baseline findings from the first two years of the KIDS-STEP trial
  50. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
  51. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland
  52. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
  53. Implementation of an electronic, secure, web-based application to support routine hand hygiene observation with immediate direct feedback and anonymized benchmarking
  54. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
  55. Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
  56. Swiss recommendations on perioperative antimicrobial prophylaxis in children
  57. Lifestyle Behaviours of Children and Adolescents During the First Two Waves of the COVID-19 Pandemic in Switzerland and Their Relation to Well-Being: An Observational Study
  58. Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland
  59. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  60. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
  61. Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type
  62. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas
  63. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
  64. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
  65. The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results
  66. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
  67. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
  68. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
  69. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
  70. SwissPedData: Standardising hospital records for the benefit of paediatric research
  71. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
  72. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
  73. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
  74. Children living with HIV in Europe: do migrants have worse treatment outcomes?
  75. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  76. Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)
  77. Clinical data for paediatric research: the Swiss approach
  78. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study
  79. Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
  80. Maternal outcomes and risk factors for COVID-19 severity among pregnant women
  81. Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
  82. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
  83. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review
  84. The influence of human genetic variation on Epstein–Barr virus sequence diversity
  85. Leptospirosis Followed by Kawasaki-Like Disease: Case Report From an Adult Swiss Patient and Review of the Literature
  86. Can antibody tests accurately detect prior SARS-CoV-2 infection?
  87. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
  88. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland
  89. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study
  90. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
  91. Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study
  92. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
  93. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
  94. Swiss consensus recommendations on urinary tract infections in children
  95. Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
  96. Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
  97. Whole-exome sequencing for the identification of rare variants in primary immunodeficiency genes in children with sepsis - a prospective population-based cohort study
  98. Temporal Course of SARS‐CoV‐2 Antibody Positivity in Patients with COVID‐19 following the First Clinical Presentation
  99. SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2
  100. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
  101. Nevirapine in HIV maintenance therapy – can “old drugs” survive in current HIV management?
  102. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
  103. Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study
  104. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review
  105. Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy
  106. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales
  107. Time-to-Positivity of Blood Cultures in Children With Sepsis
  108. Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
  109. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
  110. Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study
  111. Hand hygiene adherence in relation to influenza season during 6 consecutive years
  112. Akutes rheumatisches Fieber
  113. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
  114. Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
  115. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
  116. OUP accepted manuscript
  117. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland
  118. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland
  119. Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
  120. Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
  121. Syphilis: Diagnostik und Behandlung
  122. Primary cutaneous aspergillosis in a preterm neonate
  123. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung
  124. Mikrobiom – die Entdeckung eines Organs
  125. Postexpositionelle Prophylaxe (PEP) von HIV ausserhalb des Medizinalbereichs
  126. Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
  127. To Say or Not to Say: A Qualitative Study on the Disclosure of Their Condition by Human Immunodeficiency Virus–Positive Adolescents
  128. Sudden infant death syndrome in infants born to HIV-infected and opiate-using mothers
  129. Akutes Fieber beim Kleinkind
  130. Statin-induced immunomodulatory effects on human T cells in vivo
  131. Gynecomastia and potent antiretroviral therapy
  132. Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection
  133. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl
  134. Sensitization to Human Immunodeficiency Virus in Seronegative Exposed Partners